Welcome to our dedicated page for Columbia Financ SEC filings (Ticker: CLBK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Columbia Financial, Inc. filings document material events for the holding company of Columbia Bank, including furnished earnings releases, Regulation FD presentation materials, governance updates and capital-structure disclosures. Recent 8-K filings record operating and financial results, executive appointments, officer-designation matters and board succession disclosures involving the company and its wholly owned bank subsidiary.
The filing record also covers shareholder voting matters, material agreements and corporate-governance items that relate to Columbia Financial’s public-company reporting obligations. These disclosures connect the company’s banking operations with formal records on financial performance, management responsibilities, board composition and securities-related actions.
Columbia Financial, Inc. reported stronger quarterly results and detailed a planned corporate reorganization with an acquisition. For the three months ended March 31, 2026, net income rose to $13.1 million from $8.9 million, with diluted EPS increasing to $0.13 from $0.09. Net interest income grew to $60.4 million while the provision for credit losses declined to $1.0 million. Total assets were $11.0 billion, including $8.21 billion of gross loans and $8.37 billion of deposits. Asset quality remained manageable with non-accrual loans of $41.4 million and an allowance for credit losses on loans of $68.8 million. The company also recorded an other comprehensive loss of $1.9 million driven largely by unrealized losses on securities.
Strategically, Columbia outlined a proposed second-step conversion from a mutual holding company to a fully public stock holding company and an agreement to acquire Northfield Bancorp, Inc.. Following the conversion, Northfield will merge into a new Maryland holding company, which will become the parent of Columbia Bank. Each Northfield share will be exchanged for either stock or cash, with consideration ranging from 1.425–1.465 shares of new holding company stock or $14.25–$14.65 in cash per share, depending on the final independent valuation, subject to regulatory and stockholder approvals and a cap on the cash portion.
Columbia Financial, Inc. EVP & CIO Prabhu Manesh Balachandran reported compensation-related equity changes, mainly tied to performance awards and benefit plans, rather than open-market trading. The company determined that out of a performance-based restricted stock grant from May 1, 2023, 1,454 shares would vest and 7,267 shares would be forfeited based on results over the performance period.
The filing also shows a tax-withholding disposition of 830 shares of common stock at $19.25 per share, leaving 7,097 common shares held directly. Balachandran continues to hold additional common stock indirectly through stock awards, ESOP, 401(k), SERP and a stock-based deferral plan, and has phantom stock units economically equivalent to 7,669 shares that will be settled in cash. He also retains several blocks of vested and unvested stock options with exercise prices between the mid-teens and low twenties per share and expirations from 2032 to 2036, indicating a continuing equity-based stake aligned with the company’s long-term performance.
Columbia Financial, Inc. executive Mayra Liseth Rinaldi, EVP of Corporate Governance & Culture, reported routine updates to her equity holdings. The filing shows that 6,460 shares of performance-based restricted stock were forfeited back to the company after performance goals were not fully met, while 1,292 shares vested, as described in the footnotes.
In a separate line item, 739 common shares were disposed of at $19.25 per share to cover tax obligations, a non-market transaction coded as tax withholding. After these changes, she directly holds 20,169 common shares and has additional indirect holdings through plans such as ESOP and 401(k). She also retains multiple stock option grants, including 49,412 options exercisable at $15.60 per share expiring in 2029, plus newer options at higher exercise prices and 4,756 phantom stock units that will be settled in cash.
Columbia Financial, Inc. executive Lewis Oliver Edward Jr., SEVP & Head of Commercial Banking, reported routine equity compensation adjustments. On May 1, 2026, the company determined that, from a performance-based restricted stock grant made on May 1, 2023, 1,990 shares would vest and 9,948 shares would be forfeited, recorded as a disposition to the issuer.
The filing also shows a tax-withholding disposition of 1,200 shares of common stock at $19.25 per share. A footnote states the form reflects increases in beneficial ownership from exempt acquisitions under Rule 16b-3(c). Edward continues to hold indirect interests through stock awards and plans, as well as multiple stock option grants, including options on 57,026 shares at an exercise price of $17.86 expiring on March 22, 2031 and options on 20,000 shares at $18.28 expiring on March 2, 2036.
Columbia Financial, Inc. executive John Klimowich, SEVP & Chief Risk Officer, reported updates to his equity holdings. The company determined that of a performance-based restricted stock grant made on May 1, 2023, 2,067 shares will vest and 10,336 shares are forfeited, reflected as a disposition to the issuer. Separately, 1,247 shares of common stock at $19.25 were withheld to cover tax obligations, a non-market transaction. Following these changes, he holds 64,909 common shares directly and additional indirect interests, including 9,077.7004 shares through a stock-based deferral plan. Klimowich also retains stock options, including awards covering 188,235 underlying shares at a $15.60 exercise price expiring in July 2029, along with several newer option grants vesting in future years.
Columbia Financial, Inc. executive Allyson Katz Schlesinger, SEVP & Head of Consumer Banking, reported compensation-related share adjustments tied to performance-based awards. On May 1, 2026 the company determined that 2,171 performance-based restricted shares would vest and 10,852 shares would be forfeited back to the issuer. To cover tax obligations on the vesting, 1,309 common shares were withheld at $19.25 per share. After these dispositions, she directly holds 68,623 common shares, along with multiple stock-based awards and stock options granted under the 2019 Equity Incentive Plan, some of which are fully vested and exercisable.
Gibney Dennis E. reported disposition transactions in this Form 4 filing.
Columbia Financial, Inc. executive Dennis E. Gibney reported a compensation-related adjustment to his holdings. The company determined that of certain performance-based restricted stock granted on May 1, 2023, 11,512 shares would be forfeited to the issuer and 2,302 shares would vest based on performance through May 1, 2026. After these changes, he holds 161,860 shares of common stock directly, along with multiple indirect positions through stock awards, retirement plans, and a spouse account. He also retains several blocks of employee stock options under the 2019 Equity Incentive Plan, including 240,000 options at $15.60 expiring in 2029 and additional tranches expiring between 2033 and 2036. The form notes that some increases in beneficial ownership arose from exempt acquisitions under Rule 16b-3(c), indicating routine equity compensation activity rather than open-market trading.
Columbia Financial, Inc. President & CEO Thomas J. Kemly reported routine updates to his equity holdings. On May 1, 2026, he forfeited 32,558 shares of performance-based restricted stock back to the company after performance objectives were not fully achieved, while 6,512 shares from the same May 1, 2023 grant were determined to vest. He also acquired 96.5034 phantom stock units at $19.25 per unit through a non-qualified stock-based deferral plan, to be settled in shares upon distribution. Following the disposition, he held 249,269 shares of common stock directly, alongside indirect and deferred holdings and a substantial package of vested and vesting stock options.
Columbia Financial, Inc. filed Amendment No. 1 to its Form 10‑K for the year ended December 31, 2025 to add the previously omitted Part III information and update the share count. The cover now reports 104,142,951 common shares outstanding as of April 27, 2026 and non‑affiliate equity market value of $354.6 million as of June 30, 2025.
The amendment details the board and executive team, including long‑tenured CEO Thomas J. Kemly, and notes two directors will not stand for re‑election while two banking executives are nominated for three‑year board terms. It describes the Code of Ethics, audit committee structure, insider‑trading and Section 16(a) compliance, and extensive use of independent advisors for compensation decisions.
Columbia explains its pay‑for‑performance philosophy for named executive officers, combining base salary, annual cash incentives under the Performance Achievement Incentive Program and equity under the 2019 Equity Plan. For 2025, corporate goals were based on core bank net income, core efficiency ratio and non‑performing assets, leading to PAIP payouts of about 83%–90% of target. A 2025 “say on pay” vote passed with 99.2% support, and the company outlines stock ownership guidelines, anti‑hedging and clawback policies, and overfunded pension and supplemental retirement arrangements.
Columbia Financial, Inc. approved new two-year employment agreements for five senior executives, effective April 1, 2026, with automatic one-year renewals each April 1 unless either party gives timely notice.
The agreements set 2026 base salaries of $700,000 for Dennis E. Gibney, $470,000 for Allyson Schlesinger, $445,000 for John Klimowich, $440,000 for Oliver E. Lewis, Jr., and $430,000 for Manesh Prabhu. Executives are eligible for annual Target Bonuses, long‑term equity awards under the company's LTIP and equity plan, and participation in standard benefit and expense reimbursement programs.
If employment is terminated without cause, each executive receives cash severance equal to two times base salary plus Target Bonus and continued health coverage support. If termination without cause or resignation for good reason occurs within 24 months after a change in control, cash severance increases to three times base salary plus Target Bonus, an additional prior‑year bonus amount, and a lump sum for 36 months of continued medical, vision, and dental coverage. The agreements also provide one‑times salary‑plus‑bonus payments upon death or disability and include 24‑month non‑competition and non‑solicitation covenants, perpetual confidentiality, and mutual non‑disparagement.